Med. praxi. 2012;9(10):385-387

Guidelines for the treatment of lower respiratory tract infections for general practitioners

MUDr.Monika ®urková, prof.MUDr.Vítězslav Kolek, DrSc.
Klinika plicních nemocí a TBC FN Olomouc

The article deals with the current therapeutic options in lower respiratory tract infections. It mentions optimal empirical use of antibiotics

in the most common conditions, such as acute tracheobronchitis, exacerbations of chronic bronchitis, exacerbations of chronic obstructive

pulmonary disease, and pneumonia. The choice of drugs is guided by the current knowledge of their efficacy, availability, and with

respect to emergent resistances. Valid clinical guidelines that the article is based on are presented.

disease, pneumonia, antibiotic therapy.

Keywords: acute tracheobronchitis, acute exacerbations of chronic bronchitis, acute exacerbations of chronic obstructive pulmonary

Published: November 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
®urková M, Kolek V. Guidelines for the treatment of lower respiratory tract infections for general practitioners. Med. praxi. 2012;9(10):385-387.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Kolek V, Kaąák V, Vaąáková M. Pneumologie. Praha: Maxdorf 2011: 170-201.
    2. Karen I, Havlík J, Kolek V, Matouąková M. Racionální antibiotická terapie respiračních a koľních infekcí. 2011: 7-10.
    3. Kolek V, Kolář M, Kaąák V, et al. Diagnostika a léčba komunitní pneumonie dospělých. Doporučený postup. Vnitř Lék 2011; 57(10): 858-866. Go to PubMed...
    4. Johannes M, Daniels A, Schoorl M, et al. Procalcitonin vs C-Reactive Protein as Predictive Markers of Response to Antibiotic Therapy in Acute Exacerbations of COPD. CHEST 2010; 138(5): 1108-1115. Go to original source... Go to PubMed...
    5. Bafadhel MW, Tristan C, Carlene R, et al. Procalcitonin and C-Reactive Protein in Hospitalized Adult Patients With Community - Acquired Pneumonia or Exacerbation of Astma or COPD. CHEST 2011; 139(6): 1410-1418. Go to original source... Go to PubMed...
    6. Koutsokera A, Stolz D, Loukides S, et al. Systemic biomarkers in exacerbations of COPD. The evolving clinical challenge. Chest 2012; 212(2): 396-405. Go to original source... Go to PubMed...
    7. Woodhead M, Blasi F, Ewig S, et al. Joint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases: Guidelines for the management of adult lower respiratory tract. Infections. Clin Microbiol Infect 2011; 17(Suppl 6): 1-24. Go to original source... Go to PubMed...
    8. Kolek V. Respirační fluorochinolon moxifloxacin a jeho vyuľití v pneumologii Stud Pneumol Phthiseol., 2010; 70(4): 159-166.

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.